AIM
ACHN

Assured Investment Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Assured Investment Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-262,627
Closed -$777K – 1076
2019
Q1 		$777K Sell
262,627
-24,344
-8% -$59.8K 0.01% 442
2018
Q4 		$456K Buy
286,971
+266,490
+1,301% +$753K 0.01% 687
2018
Q3 		$75K Sell
20,481
-35,756
-64% -$107K ﹤0.01% 1068
2018
Q2 		$159K Buy
+56,237
New +$192K ﹤0.01% 1025

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Assured Investment Management's ACHN Position: Q2 2019 in Review

Assured Investment Management sold out of Achillion Pharmaceuticals (ACHN) in Q2 2019, closing a stake of 262,627 shares — an estimated $777K sold.

Assured Investment Management first reported a position in ACHN in Q2 2018 and held it in 4 quarters. The position peaked at $777K in Q1 2019. 114 funds tracked by Wall St. Rank hold ACHN as of Q2 2019.

  • Assured Investment Management reported no remaining Achillion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 262,627 Achillion Pharmaceuticals shares in Q2 2019, an estimated $777K.
  • Assured Investment Management first reported a position in Achillion Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Assured Investment Management's Achillion Pharmaceuticals position peaked at $777K in Q1 2019.
  • 114 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.